Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 641288105 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
First Light Asset Management, LLC
13G/A
Amendment 1
|
12.3% |
9/4/2026
Event 8/31/2026
|
|
| First Light Asset Management, LLC | 11.8% | ||
| Mathew P. Arens | 12.3% | ||
|
OrbiMed Advisors LLC
13G/A
Amendment 8
|
4.4% |
8/14/2026
Event 6/30/2026
|
|
| OrbiMed Advisors LLC | 4.4% | ||
| OrbiMed Capital GP VI LLC | 4.4% | ||
|
First Light Asset Management, LLC
13G
|
8.7% |
5/15/2026
Event 3/31/2026
|
|
| First Light Asset Management, LLC | 8.4% | ||
| Mathew P. Arens | 8.7% | ||
|
OrbiMed Advisors LLC
13G/A
Amendment 7
|
6.2% |
5/15/2026
Event 3/31/2026
|
|
| OrbiMed Advisors LLC | 6.2% | ||
| OrbiMed Capital GP VI LLC | 6.2% | ||
|
Soleus Private Equity Fund I, L.P.
13G/A
Amendment 6
|
8.9% |
11/7/2025
Event 9/30/2025
|
|
| Soleus Private Equity Fund I, L.P. | 0.9% | ||
| Soleus Private Equity GP I, LLC | 0.9% | ||
| Soleus PE GP I, LLC | 0.9% | ||
| Soleus Capital Master Fund, L.P. | 7.9% | ||
| Soleus Capital, LLC | 7.9% | ||
| Soleus Capital Group, LLC | 7.9% | ||
| Soleus Capital Management, L.P. | 8.9% | ||
| Soleus GP, LLC | 8.9% | ||
| Guy Levy | 8.9% | ||
| KCK Ltd. 13G/A Amendment 4 | 0% |
9/3/2025
Event 2/20/2025
|
|
|
OrbiMed Advisors LLC
13G/A
Amendment 6
|
8.0% |
8/14/2025
Event 6/30/2025
|
|
| OrbiMed Advisors LLC | 8.0% | ||
| OrbiMed Capital GP VI LLC | 8.0% | ||
|
Soleus Capital Master Fund, L.P.
13G/A
Amendment 5
|
7.0% |
8/5/2025
Event 6/30/2025
|
|
| Soleus Private Equity Fund I, L.P. | 0.9% | ||
| Soleus Private Equity GP I, LLC | 0.9% | ||
| Soleus PE GP I, LLC | 0.9% | ||
| Soleus Capital Master Fund, L.P. | 6.1% | ||
| Soleus Capital, LLC | 6.1% | ||
| Soleus Capital Group, LLC | 6.1% | ||
| Soleus Capital Management, L.P. | 7.0% | ||
| Soleus GP, LLC | 7.0% | ||
| Guy Levy | 7.0% | ||
|
Polar Capital Holdings Plc
13G
|
9.1% |
5/15/2025
Event 3/31/2025
|
|
| Polar Capital Holdings Plc | 9.1% | ||
| Polar Capital LLP | 9.1% | ||
|
OrbiMed Advisors LLC
13G/A
Amendment 5
|
10.5% |
5/15/2025
Event 3/31/2025
|
|
| OrbiMed Advisors LLC | 10.5% | ||
| OrbiMed Capital GP VI LLC | 10.5% | ||
|
Kent Lake PR LLC
13G/A
Amendment 1
|
4.9% |
2/14/2025
Event 12/31/2024
|
|
| Kent Lake PR LLC | 4.9% | ||
| Kent Lake Partners LP | 4.9% | ||
| Benjamin Natter | 4.9% | ||
| KCK Ltd. 13G/A Amendment 3 | 17.7% |
2/11/2025
Event 12/31/2024
|
|
|
Morgan Stanley
13G/A
Amendment 2
|
8.3% |
2/4/2025
Event 12/31/2024
|
|
| Morgan Stanley | 8.3% | ||
| Morgan Stanley Capital Services LLC | 8.2% | ||
|
Kent Lake PR LLC
13G
|
5.0% |
11/4/2024
Event 10/25/2024
|
|
| Kent Lake PR LLC | 5.0% | ||
| Kent Lake Partners LP | 5.0% | ||
| Benjamin Natter | 5.0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 2 | 15.0 | $206.00 |
| 2026 Q2 | 114 | 26.6 M | $423 M |
| 2026 Q1 | 115 | 26.5 M | $348 M |
| 2025 Q4 | 102 | 26.3 M | $406 M |
| 2025 Q3 | 84 | 26.0 M | $268 M |
| 2025 Q2 | 109 | 22.5 M | $251 M |
| 2025 Q1 | 94 | 23.9 M | $294 M |
| 2024 Q4 | 67 | 20.9 M | $234 M |
| 2024 Q3 | 52 | 14.8 M | $103 M |
| 2024 Q2 | 58 | 17.5 M | $132 M |
| 2024 Q1 | 62 | 18.4 M | $242 M |
| 2023 Q4 | 45 | 16.3 M | $168 M |
| 2023 Q3 | 26 | 18.1 M | $176 M |
| 2023 Q2 | 23 | 17.5 M | $78.6 M |
| 2023 Q1 | 25 | 17.7 M | $82.0 M |
| 2022 Q4 | 26 | 17.4 M | $25.9 M |
| 2022 Q3 | 29 | 18.2 M | $68.1 M |
| 2022 Q2 | 33 | 18.4 M | $91.2 M |
| 2022 Q1 | 41 | 18.2 M | $150 M |
| 2021 Q4 | 43 | 18.0 M | $182 M |
| 2021 Q3 | 41 | 11.2 M | $177 M |
| 2021 Q2 | 46 | 10.9 M | $259 M |